Tuesday after markets closed that patients taking Biogen’s Aduhelm will have to also participate in

Biogen expects “ minimal ” sales this year from its Alzheimer’s treatment initially hailed as a

A new Alzheimer’s drug from Biogen brought in only$ 300, 000 in sales during its first full quarter

Biogen is slashing the price of its Alzheimer’s treatment in half months after it debuted to

that would generate billions for Biogen. But doctors have been hesitant to prescribe it, given weak

This image provided by Biogen on June 7, 2021 shows a vial and packaging for the drug Aduhelm

Medicare attributed about half of this year’s increase to contingency planning for Aduhelm

NEW YORK--Stocks that traded heavily or had substantial price changes Monday: Biogen Inc., down

The Biogen Inc., headquarters is shown March 11, 2020, in Cambridge, Mass.... The drug is the

Stocks that traded heavily or had substantial price changes Thursday: WD-40 Co., up$ 1.26 to$ 261.80. The maintenance and cleaning product company reported strong fiscal third-quarter financial results. Helen of Troy Ltd., down$ 14.01 to$ 218.51. Investors were disappointed by the personal and household products company's financial forecast. Kansas City Southern, down$ 22.46 to$ 262.79. The Biden administration is reportedly pushing regulators to focus on anticompetitive practices in the railroa